Zacks Analyst Blog Highlights: Comerica, Energizer Holdings, Inc., GlaxoSmithKline, CACI International and United Parcel Service, Inc

Business Wire, Jan 12, 2009

CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Comerica (NYSE: CMA), Energizer Holdings, Inc. (NYSE: ENR), GlaxoSmithKline (NYSE: GSK), CACI International (NYSE: CAI) and United Parcel Service, Inc. (NYSE: UPS).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Friday's Analyst Blog:

Comerica Still a Sell Pre-Earnings

Comerica (NYSE: CMA) is a Detroit-based banking and financial services company. With nearly 10,350 employees and 400 banking offices, CMA is one of the top 20 banks in the country.

CMA is scheduled to release its 4Q08 financial results on January 22, 2008. Excluding the one-time items, 3Q08 operating earnings came in at $0.52 per diluted share, two pennies short of our estimate.

Energizer with Plenty of Juice

Energizer Holdings, Inc. (NYSE: ENR) has generated top-line growth both through organic growth in the razor blade and battery businesses and though the acquisition of Playtex and Hawaiian Tropic.

In addition, integration savings, originally estimated to be $57 million, was increased to $70 million. Management is incentivized with annual and two-year bonus plans and a stock incentive plan. Historically, management has been successful in qualifying for performance-based awards.

Glaxo a Big-Pharma Hold

GlaxoSmithKline (NYSE: GSK) is the world's second largest pharmaceutical company, with global operations based in the U.K. and the U.S.

Although Glaxo has made significant progress with its late-stage pipeline, we are worried about the recent negative news surrounding the company's second-largest-selling drug Avandia, as well as generic competition to several other products. Sales of Avandia have plummeted, but we think they're close to bottoming.

CACI Int'l Secures a Buy Rec

Based in Arlington, Virginia, CACI International (NYSE: CAI) delivers the IT applications and infrastructure used to improve communications and collaboration, secure the integrity of information systems and networks, enhance data collection and analysis, and increase efficiency and mission effectiveness. The company's solutions enhance defense and intelligence capabilities, assure homeland security, improve decision-making and help customers operate smarter, faster and more responsibly.

We remain positive about CAI's long-term prospects. We think the trend towards outsourcing by the federal government to modernize mission-critical information systems to be intact. Management expects to generate revenues of $5 billion by 2012, derived from both organic growth and acquisitions.

UPS Keeps Delivering

We are retaining our Buy on United Parcel Service, Inc. (NYSE: UPS), as well as our $60 target price. UPS will report 4th quarter results on February 3.

We are cutting our 2008 diluted EPS estimate to $3.55 from $3.57, toward the lower end of UPS guidance of $3.50-3.70, and to $3.35 from $3.75 for 2009, as we have reduced our revenue and share repurchase estimates due to the global economic slowdown.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.